Biographical Sketch
Bret A. Lashner, MD, is Director of the Center for Inflammatory Bowel Disease in the Department of Gastroenterology at Cleveland Clinic in Cleveland, Ohio. Dr. Lashner is board-certified in internal medicine and gastroenterology, and he specializes in ulcerative colitis, Crohn's disease, and general gastrointestinal disease. In 1999, he was awarded the Premier Physician Award from the Crohn's and Colitis Foundation of America.
A frequent lecturer at national and international meetings, Dr. Lashner also serves on the editorial boards of peer-reviewed publications, including the American Journal of Gastroenterology, Journal of Clinical Gastroenterology and Inflammatory Bowel Diseases. He has served as principal investigator for many clinical trials on inflammatory bowel disease and has published extensively on clinical aspects of inflammatory bowel disease.
Dr. Lashner is a member of the American Gastroenterological Association, American Society for Gastrointestinal Endoscopy and the Crohn's and Colitis Foundation of America. He is a fellow of the American College of Gastroenterology.
Dr. Lashner received his medical degree from New York University and completed his internal medicine residency at Temple University Hospital in Philadelphia. He completed a fellowship in gastroenterology at the University of Chicago, and obtained his Master of Public Health from the University of Illinois at Chicago.
Specialty Interests
clinical epidemiology, Crohn's Disease, general gastrointestinal disease, Ulcerative Colitis
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 9/4/2008, Dr.
Lashner has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Lashner receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Abbott
Elan Pharmaceuticals
Procter & Gamble
Prometheus
Shire Development Inc.
UCB Pharma, Inc.
